Globus Medical Rg-A
GMED
USD
STOCK MARKET:
NYX
Open
 
...
Large gap with delayed quotes
Last quote
09/03/2025 - 19:50:10
Bid
09/03/2025 - 19:52:04
Bid
Volume
Ask
09/03/2025 - 19:52:04
Ask
Volume
58.85
-1.05 ( -1.75% )
58.85
100
58.90
100
More information
Analysis by TheScreener
02.09.2025
Evaluation Neutral  
Interest Strong  
Sensibility Middle  
Analysis date: 02.09.2025
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 09.05.2025.
Interest
  Strong
Three stars since 02.09.2025.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 29.08.2025 at a price of 61.27.
Evaluation
  Neutral
 
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 08.08.2025.
4wk Rel Perf
  10.95%
 
The four-week dividend-adjusted overperformance versus SP500 is 10.95%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 09.05.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by 0.02%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.96%.
Mkt Cap in $bn
  8.27
With a market capitalization >$8bn, GLOBUS MEDICAL INCO. is considered a large-cap stock.
G/PE Ratio
  0.88
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  14.87
The estimated PE is for the year 2027.
LT Growth
  13.04%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  10
Over the last seven weeks, an average of 10 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  84
For 1% of index variation, the stock varies on average by 0.84%.
Correlation
  0.47
46.76% of stock movements are explained by index variations.
Value at Risk
  11.35
The value at risk is estimated at USD 11.35. The risk is therefore 18.94%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  27.07.2018